Published in Emerg Infect Dis on July 01, 2003
Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat. J Virol (2010) 2.18
Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol (2011) 1.38
Advancing full length genome sequencing for human RNA viral pathogens. Future Virol (2009) 1.02
Viruses in a 14th-century coprolite. Appl Environ Microbiol (2014) 0.94
Translational research in infectious disease: current paradigms and challenges ahead. Transl Res (2012) 0.83
An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery. Yale J Biol Med (2016) 0.75
High abundance of viruses found in aquatic environments. Nature (1989) 15.01
Virioplankton: viruses in aquatic ecosystems. Microbiol Mol Biol Rev (2000) 12.84
Marine viruses and their biogeochemical and ecological effects. Nature (1999) 10.77
Genomic analysis of uncultured marine viral communities. Proc Natl Acad Sci U S A (2002) 9.21
The Phage Proteomic Tree: a genome-based taxonomy for phage. J Bacteriol (2002) 6.09
A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A (2001) 4.62
Purification of large quantities of influenza virus by density gradient centrifugation. J Virol (1967) 3.84
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28
Separation of subcellular components and viruses by combined rate- and isopycnic-zonal centrifugation. Natl Cancer Inst Monogr (1966) 2.50
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
K-series centrifuges. I. Development of the K-II continuous-sample-flow-with-banding centrifuge system for vaccine purification. Anal Biochem (1969) 2.18
Production of shotgun libraries using random amplification. Biotechniques (2001) 2.14
Flow cytometric detection of viruses. J Virol Methods (2000) 2.05
Genetic diversity in marine algal virus communities as revealed by sequence analysis of DNA polymerase genes. Appl Environ Microbiol (1996) 1.88
Pathogenic human viruses in coastal waters. Clin Microbiol Rev (2003) 1.57
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion (2001) 1.43
Purification of influenza virus in the K-II zonal centrifuge. Nature (1969) 1.24
Rapid virus production and removal as measured with fluorescently labeled viruses as tracers. Appl Environ Microbiol (2000) 1.22
The preparation and safety of hepatitis B vaccine. J Infect (1983) 0.93
Problems in biocontainment. Natl Cancer Inst Monogr (1966) 0.85
K-series centrifuges. 3. Effect of core taper on particle capture efficiency. Anal Biochem (1970) 0.85
K-series centrifuges. IV. Measurement and control of temperature. Anal Biochem (1970) 0.84
The birth of Big Biology. Nature (1999) 0.78
Proteomic analysis of rare molecular species of translated polypeptides from a mouse fetal thymus cDNA library. Proteomics (2001) 0.78
Mass purification of nucleopolyhedrosis virus inclusion bodies in the K-series centrifuge. Appl Microbiol (1972) 0.78
K-series centrifuges. II. Performance of the K-II rotor. Anal Biochem (1969) 0.78
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics (2009) 3.65
The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics (2003) 2.41
A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights (2007) 2.39
Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics (2003) 2.04
Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem (2009) 1.81
High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin Chem (2008) 1.62
A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report. Mol Cell Proteomics (2006) 1.60
Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics (2011) 1.52
Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol Cell (2006) 1.44
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics (2011) 1.44
Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology (2004) 1.27
Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique. J Immunol Methods (2008) 1.17
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin Chem (2009) 1.10
Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem (2009) 1.07
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation (2004) 1.07
Mass-spectrometry-based clinical proteomics--a review and prospective. Analyst (2010) 1.06
High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. J Proteome Res (2012) 1.04
Proteomics: from basic research to diagnostic application. A review of requirements & needs. J Proteome Res (2005) 1.03
Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors. Hepatology (2004) 1.02
Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother (2008) 0.99
Therapeutic potential of the plasma proteome. Curr Opin Mol Ther (2003) 0.99
Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection. Intervirology (2002) 0.97
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral Res (2004) 0.96
MALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics. J Immunol Methods (2010) 0.94
Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection. Antivir Ther (2004) 0.93
The journey to regulation of protein-based multiplex quantitative assays. Clin Chem (2011) 0.90
Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine. Antiviral Res (2002) 0.90
Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection. Hepatology (2007) 0.89
Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother (2005) 0.89
Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy. Proteomics (2002) 0.87
Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection. J Med Virol (2004) 0.87
Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks. J Virol (2006) 0.86
Proteomic analysis of rat soleus and tibialis anterior muscle following immobilization. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.86
Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks. Antimicrob Agents Chemother (2005) 0.86
Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection. Hepatology (2003) 0.81
Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer. Clin Chem (2013) 0.81
Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results. Proteomics Clin Appl (2007) 0.81
Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax). Vet Immunol Immunopathol (2002) 0.80
Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide. Arch Pathol Lab Med (2014) 0.79
Quantification of proteins using peptide immunoaffinity enrichment coupled with mass spectrometry. J Vis Exp (2011) 0.79
Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant. J Med Virol (2009) 0.78
Introduction: Advances in protein analysis for the clinical laboratory. Clin Chem (2009) 0.77
Cross-species hybridization: characterization of gene expression in woodchuck liver using human membrane arrays. J Med Virol (2004) 0.77
Painting a moving picture: large-scale proteomics efforts and their potential for changing patient care. Clin Chem (2011) 0.77
Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother (2007) 0.76
Candidate List of yoUr Biomarker (CLUB): A Web-based Platform to Aid Cancer Biomarker Research. Biomark Insights (2008) 0.76
Viral pharmacodynamic model for (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) in chronically infected woodchucks. Antivir Chem Chemother (2002) 0.76
Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences. Am J Clin Pathol (2014) 0.75